Molecular RHD screening of RhD negative donors can replace standard serological testing for RhD negative donors.

[1]  G. Daniels.  Human Blood Groups: Daniels/Human Blood Groups , 2013 .

[2]  I. Dupont,et al.  Weak D caused by a founder deletion in the RHD gene , 2012, Transfusion.

[3]  J. Chiaroni,et al.  Characterization of novel RHD alleles: relationship between phenotype, genotype, and trimeric architecture , 2012, Transfusion.

[4]  J. Bordin,et al.  RHD alleles in Brazilian blood donors with weak D or D‐negative phenotypes , 2012, Transfusion medicine.

[5]  อุดม ติ่งต้อย.  RhD Positive Among C/E+ and D- Blood Donors in Denmark , 2011 .

[6]  L. Ye,et al.  Molecular basis of the RHD gene in blood donors with DEL phenotypes in Shanghai , 2009, Vox sanguinis.

[7]  W. Flegel,et al.  The Bloodgen Project of the European Union, 2003–2009 , 2009, Transfusion Medicine and Hemotherapy.

[8]  M. Danzer,et al.  Identification of RHD alleles with the potential of anti‐D immunization among seemingly D− blood donors in Upper Austria , 2009, Transfusion.

[9]  A. Blancher,et al.  Heterogeneous molecular background of the weak C, VS+, hrB–, HrB– phenotype in black persons , 2009, Transfusion.

[10]  W. Flegel,et al.  Six years' experience performing RHD genotyping to confirm D− red blood cell units in Germany for preventing anti‐D immunizations , 2009, Transfusion.

[11]  M. Danzer,et al.  Effective molecular RHD typing strategy for blood donations , 2007, Transfusion.

[12]  W. Flegel,et al.  In‐frame triplet deletions in RHD alter the D antigen phenotype , 2006, Transfusion.

[13]  H. Yasuda,et al.  Secondary anti‐D immunization by Del red blood cells , 2005, Transfusion.

[14]  M. Uchikawa,et al.  A comprehensive analysis of DEL types: partial DEL individuals are prone to anti‐D alloimmunization , 2005, Transfusion.

[15]  C. Gabriel,et al.  Novel weak D types 31 and 32: adsorption‐elution–supported D antigen analysis and comparison to prevalent weak D types , 2005, Transfusion.

[16]  N. Eicher,et al.  Presence of RHD in serologically D–, C/E+ individuals: a European multicenter study , 2005, Transfusion.

[17]  C. Buchta,et al.  Anti‐D immunization by DEL red blood cells , 2005, Transfusion.

[18]  W. Flegel.  Homing in on D antigen immunogenicity , 2005, Transfusion.

[19]  F. Noizat‐Pirenne,et al.  RhD variants in Caucasians: consequences for checking clinically relevant alleles , 2004, Transfusion.

[20]  G. Daniels,et al.  Molecular and serologic characterization of DWI, a novel “high‐grade” partial D , 2004, Transfusion.

[21]  Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie.  Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie , 2003 .

[22]  P. Perco,et al.  RHD sequencing: a new tool for decision making on transfusion therapy and provision of Rh prophylaxis , 2001, Transfusion medicine.

[23]  W. Flegel,et al.  RHD positive haplotypes in D negative Europeans , 2001, BMC Genetics.

[24]  W. Flegel,et al.  RHD gene deletion occurred in the Rhesus box. , 2000, Blood.

[25]  W. Flegel,et al.  Weak D alleles express distinct phenotypes. , 2000, Blood.

[26]  G. Daniels,et al.  The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in africans with the Rh D-negative blood group phenotype. , 2000, Blood.

[27]  S. Urbaniak,et al.  Underreporting of mortality from RhD haemolytic disease in Scotland and its implications: retrospective review , 1997, BMJ.

[28]  W. Flegel,et al.  RHD/CE typing by polymerase chain reaction using sequence‐specific primers , 1997, Transfusion.

[29]  A. Borne,et al.  The RoHar antigenic complex is associated with a limited number of D epitopes and alloanti‐D production: a study of three unrelated persons and their families , 1996, Transfusion.

[30]  U. Hanson,et al.  The prevalence of red cell antibodies in pregnancy correlated to the outcome of the newborn: , 1995, Acta obstetricia et gynecologica Scandinavica.